Dr Reddy's API Facility Inspection Closed as VAI by USFDA

Dr Reddy's Laboratories Ltd has announced the closure of a USFDA inspection at its API manufacturing facility in Mirfield, UK. The inspection, initially disclosed on September 8, 2025, has been classified as 'Voluntary Action Indicated (VAI)'. The USFDA has officially closed the inspection under 21 CFR 20.64(d)(3), indicating a satisfactory outcome for the facility's operations. This classification suggests that while some observations may have been made, they do not currently warrant mandatory regulatory action from the USFDA.